ÂÜÀòÂÒÂ×

Stephan has held senior and executive leadership & strategy roles in a wide range of biotech firms, most of them publicly held, each of them pioneers in novel platforms such as synthetic biology, nanotechnology, RNAi, and fermentation-produced specialty ingredients.

He has been part of billion-dollar merger transactions with big pharma; participated as a delegate at the United Nations Convention on Biological Diversity; and is a sustainability/product-life-cycle expert. Before that he was an investigative reporter for nearly 20 years covering all aspects of biotechnology.

Stephan earned his MS at the Columbia University Graduate School of Journalism, and his BS in Business & Economics at Colorado State University.